The Chromatin Regulator CHD8 Is a Context-Dependent Mediator of Cell Survival in Murine Hematopoietic Malignancies.

by Jennifer R Shingleton, Michael T Hemann
Published 2015-01-01

Inhibition of mutagenic translesion synthesis: A possible strategy for improving chemotherapy?

by Kinrin Yamanaka, Nimrat Chatterjee, Michael T Hemann, Graham C Walker
Published 2017-08-01

Integrated regulatory models for inference of subtype‐specific susceptibilities in glioblastoma

by Yunpeng Liu, Ning Shi, Aviv Regev, Shan He, Michael T Hemann
Published 2020-09-01

Author Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer

by Ruogu Qi, Yongheng Wang, Peter M. Bruno, Haihua Xiao, Yingjie Yu, Ting Li, Sam Lauffer, Wei Wei, Qixian Chen, Xiang Kang, Haiqin Song, Xi Yang, Xing Huang, Alexandre Detappe, Ursula Matulonis, David Pepin, Michael T. Hemann, Michael J. Birrer, P. Peter Ghoroghchian
Published 2020-04-01

Publisher Correction: Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer

by Ruogu Qi, Yongheng Wang, Peter M. Bruno, Haihua Xiao, Yingjie Yu, Ting Li, Sam Lauffer, Wei Wei, Qixian Chen, Xiang Kang, Haiqin Song, Xi Yang, Xing Huang, Alexandre Detappe, Ursula Matulonis, David Pepin, Michael T. Hemann, Michael J. Birrer, P. Peter Ghoroghchian
Published 2018-02-01

Nanoparticle conjugates of a highly potent toxin enhance safety and circumvent platinum resistance in ovarian cancer

by Ruogu Qi, Yongheng Wang, Peter M. Bruno, Haihua Xiao, Yingjie Yu, Ting Li, Sam Lauffer, Wei Wei, Qixian Chen, Xiang Kang, Haiqin Song, Xi Yang, Xing Huang, Alexandre Detappe, Ursula Matulonis, David Pepin, Michael T. Hemann, Michael J. Birrer, P. Peter Ghoroghchian
Published 2017-12-01

Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints

by Yi Wen Kong, Erik C. Dreaden, Sandra Morandell, Wen Zhou, Sanjeev S. Dhara, Ganapathy Sriram, Fred C. Lam, Jesse C. Patterson, Mohiuddin Quadir, Anh Dinh, Kevin E. Shopsowitz, Shohreh Varmeh, Ömer H. Yilmaz, Stephen J. Lippard, H. Christian Reinhardt, Michael T. Hemann, Paula T. Hammond, Michael B. Yaffe
Published 2020-08-01

BiTEs and CAR-Ts : immunotherapy in childhood B-cell acute lymphoblastic leukemia

by Besada, Rana Hany
Published 2018

PHF6 is a novel regulator of B-cell identity in acute lymphoblastic leukemia

by Soto-Feliciano, Yadira M. (Yadira Marie)
Published 2016

In vivo pool-based shRNA screens to identify modulators of disease progression in hematopoietic malignancies

by Meacham, Corbin Elizabeth
Published 2012

Functional genetics reveals surprises about the mechanisms of action of chemotherapeutics

by Bruno, Peter M. (Peter Michael)
Published 2016

Identification and Characterization of Modulators of Chemotherapeutic Response in Mouse Models of Cancer

by Doles, Jason (Jason David)
Published 2011

An in vivo RNAi therapy screen identifies novel mediators of leukemia-microenvironment interaction

by Cameron, Eleanor Ruth
Published 2016

PHF6 modulates the chromatin landscape in B-cell leukemia

by Bartlebaugh, Jordan Michael Elizabeth
Published 2018

Integrative multi-omics dissection of cancer cell states and susceptibility

by Liu, Yunpeng,Ph. D.Massachusetts Institute of Technology.
Published 2021

Mapping the therapy resistance landscapes of acute leukemias using in vivo functional genomics

by Ramos, Azucena.
Published 2021

Rev7 is a novel regulator of chemotherapeutic response in drug-resistant lung cancer

by Vassel, Faye-Marie.
Published 2019

Rational drug combinations design against intratumoral heterogeneity and clonal evolution

by Zhao, Boyang
Published 2016

Systems level characterizations of single and combination drug mechanisms of action in vitro and in vivo

by Pritchard, Justin (Justin Robert)
Published 2012